Publications by authors named "Jacob Glass"

Claim this Profile
D
Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype.
Pallavi Galera, Deepika Dilip, Andriy Derkach, Alexander Chan, Yanming Zhang, Jacob Glass

Blood· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia with mixed phenotype is characterized by mutations, stemness features and limited lineage plasticity.
Pallavi Galera, Deepika Dilip, Andriy Derkach, Alexander Chan, Yanming Zhang, Jacob Glass

medRxiv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The power and perils of large language models in haematology.
Jacob Glass, Olivier Elemento

Br J Haematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive chemotherapy after hypomethylating agent and venetoclax in adult acute myeloid leukemia.
Kuo-Kai Chin, Yannis Valtis, Andriy Derkach, Meira Yisraeli Salman, Leora Boussi, Jacob L Glass

Blood Neoplasia· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multilineage involvement in KMT2A-rearranged B acute lymphoblastic leukaemia: cell-of-origin, biology, and clinical implications.
Umut Aypar, Deepika Dilip, Ramya Gadde, Dory M Londono, Ying Liu, Jacob L Glass

Histopathology· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms.
Andrew J Dunbar, Robert L Bowman, Young C Park, Kavi O'Connor, Franco Izzo, Jacob L Glass

Cancer Discov· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia.
Joseph G W McCarter, David Nemirovsky, Christopher A Famulare, Noushin Farnoud, Abhinita S Mohanty, Jacob L Glass

Blood Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal.
Mark B Geyer, Brian C Shaffer, Bhavana Bhatnagar, Alice S Mims, Victoria Klein, Jacob L Glass

Blood Adv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemia.
Evan Atchley, Taylor M Weis, Andriy Derkach, Pallavi K Galera, Wenbin Xiao, Jacob Glass

Leuk Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies.
Mark A Dawson, Gautam Borthakur, Brian J P Huntly, Anastasios Karadimitris, Adrian Alegre, Jacob L Glass

Clin Cancer Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia.
Maximilian Stahl, Andriy Derkach, Noushin Farnoud, Jan Philipp Bewersdorf, Troy Robinson, Jacob L Glass

Am J Hematol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wearable sensor-based performance status assessment in cancer: A pilot multicenter study from the Alliance for Clinical Trials in Oncology (A19_Pilot2).
William A Wood, Deepika Dilip, Andriy Derkach, Natalie S Grover, Olivier Elemento, Jacob Glass

PLOS Digit Health· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.
Amish J Patel, Sarah Warda, Jesper L V Maag, Rohan Misra, Miguel A Miranda-Román, Jacob L Glass

Cancer Discov· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant.
Jan Philipp Bewersdorf, Andriy Derkach, Lohith Gowda, Kamal Menghrajani, Susan DeWolf, Jacob Glass

Leuk Lymphoma· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Reply: Machine Learning and Artificial Intelligence in Neurosurgery: Status, Prospects, and Challenges.
T Forcht Dagi, Fred G Barker Ii, Jacob Glass

Neurosurgery· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy.
Jacob L Glass, Andriy Derkach, Patrick Hilden, Amber King, Susan K Seo

Leuk Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine Learning and Artificial Intelligence in Neurosurgery: Status, Prospects, and Challenges.
T Forcht Dagi, Fred G Barker, Jacob Glass

Neurosurgery· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy.
Brian J Ball, Meier Hsu, Sean M Devlin, Maria Arcila, Mikhail Roshal, Jacob L Glass

Am J Hematol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML.
Maximilian Stahl, Kamal Menghrajani, Andriy Derkach, Alexander Chan, Wenbin Xiao, Jacob Glass

Blood Adv· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic Mutations Drive Specific, but Reversible, Epigenetic Heterogeneity States in AML.
Sheng Li, Xiaowen Chen, Jiahui Wang, Cem Meydan, Jacob L Glass

Cancer Discov· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukemia Cell of Origin Influences Apoptotic Priming and Sensitivity to LSD1 Inhibition.
Sheng F Cai, S Haihua Chu, Aaron D Goldberg, Salma Parvin, Richard P Koche, Jacob L Glass

Cancer Discov· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia.
Wenbin Xiao, Aaron D Goldberg, Christopher A Famulare, Sean M Devlin, Nghia T Nguyen, Jacob L Glass

Haematologica· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AML.
Cihangir Duy, Matt Teater, Francine E Garrett-Bakelman, Tak C Lee, Cem Meydan, Jacob L Glass

Cancer Discov· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesis.
Elodie Pronier, Robert L Bowman, Jihae Ahn, Jacob Glass, Cyriac Kandoth

Blood· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells.
Ly P Vu, Camila Prieto, Elianna M Amin, Sagar Chhangawala, Andrei Krivtsov, Jacob Glass

Nat Genet· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis